Fort, Madeline

IL-25 Induces IL-4, IL-5, and IL-13 and Th2-Associated Pathologies In Vivo

Fort, M. M., Cheung, J., Yen, D., Li, J., Zurawski, S. M., Lo, S., Menon, S., Clifford, T., Hunte, B., Lesley, R., et al. (2001) · Immunity

IL-33, ST2, and ILC PathwaysT-cell and B-cell Immunology

Cited by 1,203

Bacterial flagellin is a dominant antigen in Crohn disease

Lodes, M. J., Cong, Y., Elson, C. O., Mohamath, R., Landers, C. J., Targan, S. R., Fort, M., & Hershberg, R. M. (2004) · Journal of Clinical Investigation

Inflammatory Bowel DiseaseImmune Response and Inflammation

Cited by 802

T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice.

Davidson, N. J., Leach, M. W., Fort, M. M., Thompson-Snipes, L., Kühn, R., Müller, W., Berg, D. J., & Rennick, D. M. (1996) · The Journal of experimental medicine

Inflammatory Bowel DiseaseT-cell and B-cell Immunology

Cited by 402

A synthetic TLR4 antagonist has anti-inflammatory effects in two murine models of inflammatory bowel disease

Fort, M. M., Mozaffarian, A., Stöver, A. G., Correia, J. D. S., Johnson, D. A., Crane, R. T., Ulevitch, R. J., Persing, D. H., Bielefeldt-Ohmann, H., Probst, P., et al. (2005) · The Journal of Immunology

Immune Response and InflammationInflammatory Bowel Disease

Cited by 216

Cytokine release assays: Current practices and future directions

Finco, D., Grimaldi, C., Fort, M., Walker, M., Kiessling, A., Wolf, B., Salcedo, T., Faggioni, R., Schneider, A., Ibraghimov, A., et al. (2014) · Cytokine

Immunotoxicology and immune responsesMonoclonal and Polyclonal Antibodies Research

Cited by 106

Glucose-dependent insulinotropic polypeptide receptor therapies for the treatment of obesity, do agonists=antagonists?

Killion, E. A., Lu, S.-C., Fort, M., Yamada, Y., Véniant, M. M., & Lloyd, D. J. (2020) · Endocrine Reviews

Regulation of Appetite and ObesityPharmacology and Obesity Treatment

Cited by 94